Strategic Blueprint LLC Lowers Stake in MetLife, Inc. (NYSE:MET)

Strategic Blueprint LLC lowered its holdings in MetLife, Inc. (NYSE:METFree Report) by 47.4% in the 3rd quarter, Holdings Channel.com reports. The fund owned 2,858 shares of the financial services provider’s stock after selling 2,576 shares during the quarter. Strategic Blueprint LLC’s holdings in MetLife were worth $236,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the stock. Wolff Wiese Magana LLC boosted its holdings in MetLife by 374.3% in the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock worth $29,000 after acquiring an additional 277 shares during the period. Fortitude Family Office LLC lifted its position in shares of MetLife by 177.3% in the 3rd quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock worth $34,000 after buying an additional 266 shares during the last quarter. Bank & Trust Co acquired a new stake in MetLife during the second quarter worth about $39,000. Crewe Advisors LLC grew its holdings in shares of MetLife by 602.5% during the second quarter. Crewe Advisors LLC now owns 562 shares of the financial services provider’s stock valued at $39,000 after purchasing an additional 482 shares during the last quarter. Finally, Larson Financial Group LLC boosted its position in MetLife by 72.6% during the 2nd quarter. Larson Financial Group LLC now owns 568 shares of the financial services provider’s stock valued at $40,000 after purchasing an additional 239 shares during the period. 89.81% of the stock is currently owned by institutional investors and hedge funds.

MetLife Stock Up 0.0 %

MET stock opened at $78.43 on Friday. The company’s 50 day simple moving average is $80.59 and its 200-day simple moving average is $74.84. The company has a debt-to-equity ratio of 0.56, a current ratio of 0.16 and a quick ratio of 0.16. MetLife, Inc. has a 52-week low of $58.89 and a 52-week high of $86.94. The firm has a market capitalization of $54.93 billion, a P/E ratio of 15.81, a P/E/G ratio of 0.69 and a beta of 1.04.

MetLife (NYSE:METGet Free Report) last posted its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $2.28 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.13 by $0.15. MetLife had a net margin of 5.27% and a return on equity of 20.41%. The business had revenue of $17.82 billion during the quarter, compared to analyst estimates of $18.57 billion. During the same period in the prior year, the firm earned $1.94 earnings per share. The firm’s revenue was up 7.2% compared to the same quarter last year. As a group, equities research analysts anticipate that MetLife, Inc. will post 8.58 EPS for the current year.

MetLife Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Tuesday, November 5th will be issued a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a dividend yield of 2.78%. The ex-dividend date of this dividend is Tuesday, November 5th. MetLife’s dividend payout ratio is currently 43.95%.

Analyst Upgrades and Downgrades

Several research firms have recently commented on MET. Piper Sandler upped their price target on shares of MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 2nd. Barclays dropped their price target on shares of MetLife from $91.00 to $90.00 and set an “overweight” rating on the stock in a research report on Thursday. Wells Fargo & Company increased their price target on MetLife from $86.00 to $92.00 and gave the company an “overweight” rating in a research note on Thursday, October 10th. Citigroup boosted their price objective on MetLife from $83.00 to $89.00 and gave the stock a “buy” rating in a research note on Tuesday, July 23rd. Finally, TD Cowen started coverage on MetLife in a research note on Wednesday, October 9th. They set a “buy” rating and a $97.00 target price for the company. One analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $88.38.

View Our Latest Analysis on MET

MetLife Company Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Articles

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.